Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Refsum's Disease - Use of the intestinal lipase inhibitor, Orlistat, as a novel therapeutic approach to a complex disorder(legacy) | 81 |
| Refsum's Disease - Use of the intestinal lipase inhibitor, Orlistat, as a novel therapeutic approach to a complex disorder(legacy) | 58 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Refsum's Disease - Use of the intestinal lipase inhibitor, Orlistat, as a novel therapeutic approach to a complex disorder | 1 | 1 | 0 | 1 | 1 | 2 | 2 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 60 |
| Australia | 13 |
| Germany | 11 |
| Netherlands | 8 |
| Vietnam | 8 |
| China | 4 |
| France | 4 |
| Canada | 1 |
| Ireland | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 24 |
| Kaleen | 11 |
| Fairfield | 8 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Cambridge | 4 |
| New York | 2 |
| Zhengzhou | 2 |
| Ann Arbor | 1 |
| Boardman | 1 |